InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Pasternak Andy, Vice-Président Exécutif et Responsable Commercial. Director active across 1 company, notably Horizon Therapeutics Public Ltd Co. Cumulatively, 14 disclosures have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €3.5m. Activity tracked since 28 July 2021. The latest transaction was filed on 6 October 2023 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pasternak Andy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
56,338 shares@ US$116.5048.1% of flowOrdinary SharesSEC:0001209191-23-052364:0
27,129 shares@ US$113.027521.9% of flowOrdinary SharesSEC:0001209191-23-003733:0
88,733 sharesOrdinary SharesSEC:0001209191-23-000879:0
23,251 shares@ US$29.525.0% of flowOrdinary SharesSEC:0001209191-22-061269:0
12,421 sharesOrdinary SharesSEC:0001209191-22-055272:0
4,207 shares@ US$82.442.6% of flowOrdinary SharesSEC:0001209191-22-043548:0
762 shares@ US$85.360.5% of flowOrdinary SharesSEC:0001209191-22-036299:0
1,313 shares@ US$94.821.0% of flowOrdinary SharesSEC:0001209191-22-011331:0
48,839 sharesOrdinary SharesSEC:0001209191-22-002297:0
1,525 shares@ US$100.001.2% of flowOrdinary SharesSEC:0001209191-21-068601:0
23,251 shares@ US$29.525.1% of flowOrdinary SharesSEC:0001209191-21-063201:0
12,421 sharesOrdinary SharesSEC:0001209191-21-062706:0
23,250 shares@ US$29.525.0% of flowOrdinary SharesSEC:0001209191-21-055769:0
8,708 shares0Ordinary SharesSEC:0001209191-21-048790:0
14 of 14 declarations
About Pasternak Andy
Pasternak Andy is Executive Vice President and Chief Commercial Officer. He has 14 filings in total, all on Horizon Therapeutics Public Ltd Co, listed on XNAS, and the 14 sampled filings cover the period from 2021-07-30 to 2023-10-06. Across these recent filings, the reported sell volume is EUR 9700665 and the most common transaction nature is option exercise.
